Medical Prop SEC Filings

Medical Properties Trust, Inc. (MPW) director W. Zachary Riddle reported a sale of company stock. On 11/19/2025, he sold 59,000 shares of common stock at a weighted average price of $5.02 per share, with individual trade prices ranging from $4.99 to $5.05. After this transaction, he beneficially owned 157,100 shares of MPW common stock in direct ownership. The trades were executed in multiple transactions, and full trade details are available upon request as noted in the filing.

Medical Properties Trust (MPW) insider activity: The company’s Chairman, President and CEO, who is also a director, reported gifting 194,600 shares of common stock on 11/18/2025. The transaction is coded as a gift at a price of $0.00, meaning no sale proceeds were received. Following this charitable transfer, the reporting person directly owns 5,079,412 shares of Medical Properties Trust common stock.

Medical Properties Trust (MPW) filed a Form 144 notice for a planned sale of 59,000 shares of common stock through Charles Schwab on 11/19/2025, with an aggregate market value of $300,900. The filing states that 601,500,000 shares of common stock were outstanding and that the 59,000 shares to be sold were originally acquired from the issuer on 05/02/2011 as compensation stock grants, with payment dated 05/03/2011.

State Street Corporation filed a Schedule 13G reporting a passive stake in Medical Properties Trust (MPW). The firm reported beneficial ownership of 26,958,391 shares, representing 4.5% of the common stock as of the event date 09/30/2025.

State Street reported shared voting power over 22,164,338 shares and shared dispositive power over 26,958,391 shares, with no sole voting or dispositive power. It certified the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of MPW. The filing lists multiple asset management subsidiaries and identifies State Street as a holding company (HC).

Medical Properties Trust (MPW) reported a narrower quarterly loss and modest revenue growth. For Q3 2025, total revenues were $237,522 (thousand), up from $225,827 (thousand) a year ago. Net loss attributable to common stockholders was $77,730 (thousand), or $0.13 per share, compared with a $801,163 (thousand) loss a year earlier. Impairment charges remained, at $81,761 (thousand) this quarter versus $607,922 (thousand) last year, while interest expense rose to $132,395 (thousand).

Year‑to‑date, revenues were $701,680 (thousand) and net loss was $294,362 (thousand), both improved versus 2024. The balance sheet shows total assets of $14,924,195 (thousand) and debt of $9,616,176 (thousand). Cash and cash equivalents were $396,577 (thousand). Operating cash flow for the nine months was $70,703 (thousand). The company declared a dividend of $0.08 per share in the quarter. Shares outstanding were 601,136 (thousand) at September 30, 2025; Medical Properties Trust, Inc. reported 601.5 million shares outstanding as of November 4, 2025.

Medical Properties Trust (MPW) furnished third‑quarter 2025 results and announced a new stock repurchase program. The board approved the repurchase of up to $150 million of common stock.

Repurchases may occur through open market purchases, Rule 10b5‑1 trading plans, privately negotiated transactions, structured or derivative transactions, other equity contracts, or other permitted methods. The company is under no obligation to repurchase any shares and may begin, suspend, or terminate activity at any time at its discretion, considering liquidity, market conditions, regulatory factors, and the marginal benefit of new investments or debt reduction.

The press release covering financial results for the three and nine months ended September 30, 2025, and supplemental information were furnished as exhibits.

Medical Properties Trust (MPW): BlackRock, Inc. filed Amendment No. 4 to Schedule 13G reporting beneficial ownership of 69,021,718 shares of MPW common stock, representing 11.5% of the class as of 09/30/2025. BlackRock reports sole voting power over 67,137,679 shares and sole dispositive power over 69,021,718 shares, with no shared voting or dispositive power.

BlackRock states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. The filing notes that various persons may have rights to dividends or sale proceeds, and that no single person has more than five percent of MPW’s outstanding common shares through those interests.

Medical Properties Trust, Inc. (MPW) reported an insider withholding of stock to cover taxes: 80,644 shares of common stock were withheld from a restricted stock vesting event on 10/07/2025 at an indicated price of $5.01 per share. The filing, by Chairman, President & CEO Edward K. Aldag Jr., shows his beneficial ownership after the withholding is 5,274,012 shares, held directly. The entry is coded as F with an explanatory note stating the shares were withheld to satisfy tax withholding obligations and that this withholding "does not constitute a sale transaction." The Form 4 was signed by power of attorney and records this non‑dispositive, routine withholding tied to restricted stock vesting.

Medical Properties Trust, Inc. (MPW) insider filing shows that on 10/07/2025 a reporting person had 6,956 shares of common stock withheld at a price of $5.01 to satisfy tax withholding upon vesting of restricted stock. This action is recorded as a disposition code F but the form explains the withholding "does not constitute a sale transaction." After the withholding, the reporting person beneficially owns 481,691 shares directly. The form was filed by one reporting person who serves as SVP, Senior Advisor to the CEO.